Molecular imaging: T2-weighted CMR of the area at risk--a risky business?

Nat Rev Cardiol. 2010 Oct;7(10):547-9. doi: 10.1038/nrcardio.2010.124.

Authors

W Benjamin Wince¹, Raymond J Kim

Affiliation

¹ Duke Cardiovascular Magnetic Resonance Center, Department of Medicine, Duke University Medical Center, Box 3934, Durham, NC 27710, USA.

PMID: 20865026
DOI: 10.1038/nrcardio.2010.124

No abstract available

MeSH terms

Acute Coronary Syndrome / diagnosis*
Acute Coronary Syndrome / drug therapy
Acute Coronary Syndrome / therapy
Confidence Intervals
Humans
Magnetic Resonance Imaging, Cine / adverse effects*
Magnetic Resonance Imaging, Cine / instrumentation
Magnetic Resonance Imaging, Cine / methods
Molecular Imaging / adverse effects*
Molecular Imaging / instrumentation
Molecular Imaging / methods
Myocardial Reperfusion / adverse effects*
Myocardium*
Risk Assessment
Risk Factors
Tomography, Emission-Computed, Single-Photon